Good CEOs 2022
Hyacinth Empinado/STAT

I’m not naming a Best Biopharma CEO this year. 

I tried — doing so, after all, is an annual exercise — but in a year in which biotech and pharma mostly went sideways, none of the executives I considered stood out enough individually to win over the others. 

advertisement

On a more encouraging note, I managed to compile an impressively deep list of biopharma CEOs whose accomplishments this year deserve recognition. Let’s have a look.

STAT+ Exclusive Story

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe